Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 6 member 6 pseudogene 1 (SLC6A6P1) is classified as a pseudogene and does not encode a functional protein[4][8]. It is related to SLC6A6, which encodes a sodium- and chloride-dependent taurine transporter[5], but SLC6A6P1 itself does not appear to have a role in physiological function, disease, or drug response. Pseudogenes are typically non-functional segments of DNA that resemble functional genes but generally lack the ability to encode a protein product. Thus, SLC6A6P1 is not considered a therapeutic target or a functional transporter. Key details supporting these conclusions: - SLC6A6P1 is explicitly listed as a pseudogene in curated databases[4][8]. - There is no evidence that SLC6A6P1 encodes a protein, participates in biological pathways, or has implications in disease or therapy. - The nomenclature is correct, but SLC6A6P1 is not a viable drug target. If information regarding the functional gene (SLC6A6, taurine transporter) is needed, refer specifically to SLC6A6, not SLC6A6P1[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 6 member 6 pseudogene 1 (SLC6A6P1).